Beijing InnoCare Pharma's Unattributed VC Round

Beijing InnoCare Pharma raised a round of funding on February 09, 2018.

Beijing InnoCare Pharma (诺诚健华) is developing multiple candidate products that are designed to modulate the immune system in order to treat the autoimmune disease and cancers. Its products are …

Articles about Beijing InnoCare Pharma's Unattributed VC Round: